Home / Drugs / Starting with C / |
||||
Cefoxitin |
||||
indicationFor the treatment of serious infections caused by susceptible strains microorganisms.pharmacologyCefoxitin is a cephamycin antibiotic often grouped with the second-generation cephalosporins. It is active against a broad range of gram-negative bacteria including anaerobes. The methoxy group in the 7a position provides cefoxitin with a high degree of stability in the presence of beta-lactamases, both penicillinases and cephalosporinases, of gram-negative bacteria.mechanism of actionThe bactericidal action of cefoxitin results from inhibition of cell wall synthesis.toxicityThe acute intravenous LD50 in the adult female mouse and rabbit was about 8.0 g/kg and greater than 1.0 g/kg, respectively. The acute intraperitoneal LD50 in the adult rat was greater than 10.0 g/kg.biotransformationMinimal (approximately 85 percent of cefoxitin is excreted unchanged by the kidneys over a 6-hour period).half lifeThe half-life after an intravenous dose is 41 to 59 minutes.route of eliminationApproximately 85 percent of cefoxitin is excreted unchanged by the kidneys over a 6-hour period, resulting in high urinary concentrations. Cefoxitin passes into pleural and joint fluids and is detectable in antibacterial concentrations in bile.drug interactionsAcenocoumarol: The cephalosporin, cefoxitin, may increase the anticoagulant effect of acenocoumarol.Amikacin: Increased risk of nephrotoxicity Anisindione: The cephalosporin, cefoxitin, may increase the anticoagulant effect of anisindione. Dicumarol: The cephalosporin, cefoxitin, may increase the anticoagulant effect of dicumarol. Gentamicin: Increased risk of nephrotoxicity Kanamycin: Increased risk of nephrotoxicity Neomycin: Increased risk of nephrotoxicity Netilmicin: Increased risk of nephrotoxicity Probenecid: Probenecid may increase the serum level of cefoxitin. Streptomycin: Increased risk of nephrotoxicity Tobramycin: Increased risk of nephrotoxicity Warfarin: The cephalosporin, cefoxitin, may increase the anticoagulant effect of warfarin. |